{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ajania pacifica (Nakai) K. Bremer and Humphries", "B-cell lymphoma", "MYC expression", "anti-cancer activities"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38785546", "DateRevised": {"Year": "2024", "Month": "05", "Day": "26"}, "Article": {"Language": ["eng"], "ELocationID": ["10.3390/cimb46050278"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "11"}], "Journal": {"ISSN": "1467-3045", "JournalIssue": {"Volume": "46", "Issue": "5", "PubDate": {"Year": "2024", "Month": "May", "Day": "11"}}, "Title": "Current issues in molecular biology", "ISOAbbreviation": "Curr Issues Mol Biol"}, "ArticleTitle": "<i>Ajania pacifica</i> (Nakai) K. Bremer and Humphries Extract Limits MYC Expression to Induce Apoptosis in Diffuse Large B Cell Lymphoma.", "Pagination": {"StartPage": "4580", "EndPage": "4594", "MedlinePgn": "4580-4594"}, "Abstract": {"AbstractText": ["The proto-oncogene MYC is frequently dysregulated in patients with diffuse large B-cell lymphoma (DLBCL) and plays a critical role in disease progression. To improve the clinical outcomes of patients with DLBCL, the development of strategies to target MYC is crucial. The use of medicinal plants for developing anticancer drugs has garnered considerable attention owing to their diverse mechanisms of action. In this study, 100 plant extracts of flora from the Republic of Korea were screened to search for novel agents with anti-DLBCL effects. Among them, <i>Ajania pacifica</i> (Nakai) K. Bremer and Humphries extract (APKH) efficiently suppressed the survival of DLBCL cells, while showing minimal toxicity toward normal murine bone marrow cells. APKH suppressed the expression of anti-apoptotic BCL2 family members, causing an imbalance between the pro-apoptotic and anti-apoptotic BCL2 members. This disrupted mitochondrial membrane potential, cytochrome c release, and pro-caspase-3 activation and eventually led to DLBCL cell death. Importantly, MYC expression was markedly downregulated by APKH and ectopic expression of MYC in DLBCL cells abolished the pro-apoptotic effects of APKH. These results demonstrate that APKH exerts anti-DLBCL effects by inhibiting MYC expression. Moreover, when combined with doxorubicin, an essential component of the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone), APKH synergistically enhanced the therapeutic effect of doxorubicin. This indicates that APKH may overcome drug resistance, which is common in patients with refractory/relapsed DLBCL. To identify compounds with anti-DLBCL activities in APKH, the chemical profile analysis of APKH was performed using UPLC-QTOF/MS<sup>e</sup> analysis and assessed for its anticancer activity. Based on the UPLC-QTOF/MS<sup>e</sup> chemical profiling, it is conceivable that APKH may serve as a novel agent targeting MYC and sensitizing drug-resistant DLBCL cells to CHOP chemotherapy. Further studies to elucidate how the compounds in APKH exert tumor-suppressive role in DLBCL are warranted."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Woo", "ForeName": "Ye-Rin", "Initials": "YR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Kwon", "ForeName": "Chan-Seong", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Lee", "ForeName": "Ji-Eun", "Initials": "JE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Jeon", "ForeName": "Byeol-Eun", "Initials": "BE"}, {"Identifier": ["0000-0001-7678-0478"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Kim", "ForeName": "Tae-Jin", "Initials": "TJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Arts and Sciences, Texas Tech University, Lubbock, TX 79409, USA."}], "LastName": "Choo", "ForeName": "Joy", "Initials": "J"}, {"Identifier": ["0000-0001-5233-4422"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Research Institute of Standard and Science, Daejeon 34113, Republic of Korea."}], "LastName": "Seo", "ForeName": "Young-Seob", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Integrated Biological Science, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}, {"Identifier": [], "Affiliation": "Department of Biological Sciences, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea."}], "LastName": "Kim", "ForeName": "Sang-Woo", "Initials": "SW"}], "GrantList": [{"GrantID": "2020R1I1A2075060 and 2022R1A4A5031503", "Agency": "National Research Foundation (NRF), Republic of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Curr Issues Mol Biol", "NlmUniqueID": "100931761", "ISSNLinking": "1467-3037"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abramson J.S., Shipp M.A. Advances in the biology and therapy of diffuse large B-cell lymphoma: Moving toward a molecularly targeted approach. Blood. 2005;106:1164\u20131174. doi: 10.1182/blood-2005-02-0687.", "ArticleIdList": ["10.1182/blood-2005-02-0687", "15855278"]}, {"Citation": "Uguroglu S., Tastan O., Klein-Seetharaman J., Leuba S. Identification of Potentially Relevant Citeable Articles using Association Rule Mining. Medchem. 2011;1:e101. doi: 10.4172/2161-0444.1000e101.", "ArticleIdList": ["10.4172/2161-0444.1000e101"]}, {"Citation": "Coiffier B., Lepage E., Bri\u00e8re J., Herbrecht R., Tilly H., Bouabdallah R., Morel P., Van Den Neste E., Salles G., Gaulard P., et al. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma. N. Engl. J. Med. 2002;346:235\u2013242. doi: 10.1056/NEJMoa011795.", "ArticleIdList": ["10.1056/NEJMoa011795", "11807147"]}, {"Citation": "Habermann T.M., Weller E.A., Morrison V.A., Gascoyne R.D., Cassileth P.A., Cohn J.B., Dakhil S.R., Woda B., Fisher R.I., Peterson B.A., et al. Rituximab-CHOP Versus CHOP Alone or with Maintenance Rituximab in Older Patients with Diffuse Large B-Cell Lymphoma. J. Clin. Oncol. 2006;24:3121\u20133127. doi: 10.1200/JCO.2005.05.1003.", "ArticleIdList": ["10.1200/JCO.2005.05.1003", "16754935"]}, {"Citation": "Sehn L.H., Donaldson J., Chhanabhai M., Fitzgerald C., Gill K., Klasa R., MacPherson N., O\u2019Reilly S., Spinelli J.J., Sutherland J., et al. Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia. J. Clin. Oncol. 2005;23:5027\u20135033. doi: 10.1200/JCO.2005.09.137.", "ArticleIdList": ["10.1200/JCO.2005.09.137", "15955905"]}, {"Citation": "Friedberg J.W. Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Hematology. 2011;2011:498\u2013505. doi: 10.1182/asheducation-2011.1.498.", "ArticleIdList": ["10.1182/asheducation-2011.1.498", "22160081"]}, {"Citation": "Nguyen L., Papenhausen P., Shao H. The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects. Genes. 2017;8:116. doi: 10.3390/genes8040116.", "ArticleIdList": ["10.3390/genes8040116", "PMC5406863", "28379189"]}, {"Citation": "Dong Y., Tu R., Liu H., Qing G. Regulation of cancer cell metabolism: Oncogenic MYC in the driver\u2019s seat. Signal Transduct. Target. Ther. 2020;5:124. doi: 10.1038/s41392-020-00235-2.", "ArticleIdList": ["10.1038/s41392-020-00235-2", "PMC7351732", "32651356"]}, {"Citation": "Campo E. MYC in DLBCL: Partners matter. Blood. 2015;126:2439\u20132440. doi: 10.1182/blood-2015-10-671362.", "ArticleIdList": ["10.1182/blood-2015-10-671362", "26612895"]}, {"Citation": "Green D. The Coming Decade of Cell Death Research: Five Riddles. Cell. 2019;177:1094\u20131107. doi: 10.1016/j.cell.2019.04.024.", "ArticleIdList": ["10.1016/j.cell.2019.04.024", "PMC6534278", "31100266"]}, {"Citation": "Tsuyama N., Sakata S., Baba S., Mishima Y., Nishimura N., Ueda K., Yokoyama M., Terui Y., Hatake K., Kitagawa M., et al. BCL2 expression in DLBCL: Reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation. Blood. 2017;130:489\u2013500. doi: 10.1182/blood-2016-12-759621.", "ArticleIdList": ["10.1182/blood-2016-12-759621", "28522442"]}, {"Citation": "Hermeking H., Eick D. Mediation of c-Myc-Induced Apoptosis by p53. Science. 1994;265:2091\u20132093. doi: 10.1126/science.8091232.", "ArticleIdList": ["10.1126/science.8091232", "8091232"]}, {"Citation": "Kirkin V., Joos S., Z\u00f6rnig M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2004;1644:229\u2013249. doi: 10.1016/j.bbamcr.2003.08.009.", "ArticleIdList": ["10.1016/j.bbamcr.2003.08.009", "14996506"]}, {"Citation": "Yu Y., Dong W., Li X., Yu E., Zhou X., Li S. Significance of c-Myc and Bcl-2 Protein Expression in Nasopharyngeal Carcinoma. Arch. Otolaryngol.\u2013Head Neck Surg. 2003;129:1322\u20131326. doi: 10.1001/archotol.129.12.1322.", "ArticleIdList": ["10.1001/archotol.129.12.1322", "14676159"]}, {"Citation": "Nam J., Kim D.U., Kim E., Kwak B., Ko M.J., Oh A.Y., Park B.J., Kim Y.W., Kim A., Sun H., et al. Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival. Leukemia. 2019;33:2912\u20132923. doi: 10.1038/s41375-019-0492-y.", "ArticleIdList": ["10.1038/s41375-019-0492-y", "31138843"]}, {"Citation": "Kwon C.S., Lee J.E., Jeon B.E., Woo Y.R., Kim Y.S., Kim J.W., Park C.J., Jang S.Y., Kim S.W. Anti-Leukemic Effects of Idesia polycarpa Maxim Branch on Human B-Cell Acute Lymphoblastic Leukemia Cells. Curr. Issues Mol. Biol. 2023;45:4035\u20134049. doi: 10.3390/cimb45050257.", "ArticleIdList": ["10.3390/cimb45050257", "PMC10217017", "37232726"]}, {"Citation": "Kim J., Kim J.N., Park I., Sivtseva S., Okhlopkova Z., Zulfugarov I.S., Kim S.W. Dracocephalum palmatum Stephan extract induces caspase- and mitochondria-dependent apoptosis via Myc inhibition in diffuse large B cell lymphoma. Oncol. Rep. 2020;44:2746\u20132756. doi: 10.3892/or.2020.7797.", "ArticleIdList": ["10.3892/or.2020.7797", "33125144"]}, {"Citation": "Kim D., Nam J., Cha M., Kim S. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway. Oncol. Lett. 2019;17:3589\u20133598. doi: 10.3892/ol.2019.9996.", "ArticleIdList": ["10.3892/ol.2019.9996", "PMC6396110", "30867802"]}, {"Citation": "Yu X., Zhang J.Y., Liu Q., Wu Z., Liu S., Shi H., Ma Q. Chemical profiling of fifty constituents in Qi-gui-yin granule (QGY) by on-line high-performance liquid chromatography coupled with ESI-LTQ-Orbitrap mass spectrometer. Res. J. Chem. Environ. 2013;17:16\u201327."}, {"Citation": "Swerdlow S.H. Diagnosis of \u2018double hit\u2019 diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: When and how, FISH versus IHC. Hematology. 2014;2014:90\u201399. doi: 10.1182/asheducation-2014.1.90.", "ArticleIdList": ["10.1182/asheducation-2014.1.90", "25696840"]}, {"Citation": "Staudt L.M., Dave S. Advances in Immunology. Volume 87. Academic Press; Cambridge, MA, USA: 2005. The Biology of Human Lymphoid Malignancies Revealed by Gene Expression Profiling; pp. 163\u2013208.", "ArticleIdList": ["10.1016/S0065-2776(05)87005-1", "PMC1351148", "16102574"]}, {"Citation": "Goy A., Ramchandren R., Ghosh N., Munoz J., Morgan D.S., Dang N.H., Knapp M., Delioukina M., Kingsley E., Ping J., et al. Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non\u2013germinal center B-cell\u2013like DLBCL. Blood. 2019;134:1024\u20131036. doi: 10.1182/blood.2018891598.", "ArticleIdList": ["10.1182/blood.2018891598", "PMC6764267", "31331917"]}, {"Citation": "Thompson E.B. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol. 1998;60:575\u2013600. doi: 10.1146/annurev.physiol.60.1.575.", "ArticleIdList": ["10.1146/annurev.physiol.60.1.575", "9558477"]}, {"Citation": "Hu K., Li B., Ma R., Yi H., Xu Z., Peng Y., Yu D., Wu H., Cheng T., Lu Y., et al. Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: Involvement of the PI3K\u2013AKT\u2013mTOR/JNK pathway. Acta Biochim. Biophys. Sin. 2021;53:575\u2013583. doi: 10.1093/abbs/gmab031.", "ArticleIdList": ["10.1093/abbs/gmab031", "33821934"]}, {"Citation": "Xu-Monette Z.Y., Wu L., Visco C., Tai Y.C., Tzankov A., Liu W.m., Montes-Moreno S., Dybk\u00e6r K., Chiu A., Orazi A., et al. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: Report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2012;120:3986\u20133996. doi: 10.1182/blood-2012-05-433334.", "ArticleIdList": ["10.1182/blood-2012-05-433334", "PMC3496956", "22955915"]}, {"Citation": "Mishima S., Inoh Y., Narita Y., Ohta S., Sakamoto T., Araki Y., Suzuki K.M., Akao Y., Nozawa Y. Identification of caffeoylquinic acid derivatives from Brazilian propolis as constituents involved in induction of granulocytic differentiation of HL-60 cells. Bioorganic Med. Chem. 2005;13:5814\u20135818. doi: 10.1016/j.bmc.2005.05.044.", "ArticleIdList": ["10.1016/j.bmc.2005.05.044", "15993085"]}, {"Citation": "Ezzati M., Yousefi B., Velaei K., Safa A. A review on anti-cancer properties of Quercetin in breast cancer. Life Sci. 2020;248:117463. doi: 10.1016/j.lfs.2020.117463.", "ArticleIdList": ["10.1016/j.lfs.2020.117463", "32097663"]}, {"Citation": "Chen A.Y., Chen Y.C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138:2099\u20132107. doi: 10.1016/j.foodchem.2012.11.139.", "ArticleIdList": ["10.1016/j.foodchem.2012.11.139", "PMC3601579", "23497863"]}, {"Citation": "Clegg N.J., Couto S.S., Wongvipat J., Hieronymus H., Carver B.S., Taylor B.S., Ellwood-Yen K., Gerald W.L., Sander C., Sawyers C.L. MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors. PLoS ONE. 2011;6:e17449. doi: 10.1371/journal.pone.0017449.", "ArticleIdList": ["10.1371/journal.pone.0017449", "PMC3048873", "21394210"]}, {"Citation": "Granato M., Rizzello C., Romeo M.A., Yadav S., Santarelli R., D\u2019Orazi G., Faggioni A., Cirone M. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt\u2019s lymphoma. Int. J. Biochem. Cell Biol. 2016;79:393\u2013400. doi: 10.1016/j.biocel.2016.09.006.", "ArticleIdList": ["10.1016/j.biocel.2016.09.006", "27620077"]}, {"Citation": "Ott G., Rosenwald A., Campo E. Understanding MYC-driven aggressive B-cell lymphomas: Pathogenesis and classification. Blood. 2013;122:3884\u20133891. doi: 10.1182/blood-2013-05-498329.", "ArticleIdList": ["10.1182/blood-2013-05-498329", "24009228"]}, {"Citation": "Kim E., Nam J., Chang W., Zulfugarov I., Okhlopkova Z., Olennikov D., Chirikova N., Kim S.W. Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma. Sci. Rep. 2018;8:10590. doi: 10.1038/s41598-018-28619-z.", "ArticleIdList": ["10.1038/s41598-018-28619-z", "PMC6043616", "30002430"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "8"}, {"Year": "2024", "Month": "5", "Day": "3"}, {"Year": "2024", "Month": "5", "Day": "7"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "12", "Minute": "44"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "12", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "9", "Minute": "13"}, {"Year": "2024", "Month": "5", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["38785546", "PMC11119827", "10.3390/cimb46050278", "cimb46050278"]}}]}